In liver cancer, circβ-catenin produces a novel isoform of β-catenin with the length of 370-amino acids (β-catenin-370aa), and β-catenin-370aa can prevent full-length β-catenin degradation from GSK3β to thus promote activation of the Wnt-pathway [62]. Here, GSK3B is linked to liver cancer.